Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#111 / 176 Total
TUYA - Tuya Inc ADR - Stock Price Chart
TickerTUYA [NYSE]
CompanyTuya Inc ADR
CountryChina
IndustrySoftware - Infrastructure
Market Cap1.44BEPS (ttm)0.03
P/E82.12EPS this Y-20.00%
Forward P/E22.97EPS next Y13.46%
PEG15.01EPS past 5Y-
P/S4.61EPS next 5Y5.47%
P/B1.64EPS Q/Q387.30%
Dividend2.83%Sales Q/Q21.12%
Insider Own14.80%Inst Own12.23%
Insider Trans0.00%Inst Trans72.22%
Short Float0.84%EarningsMay 20/a
Analyst Recom1.20Target Price3.23
Avg Volume2.04M52W Range1.28 - 4.63
Tuya, Inc. engages in developing smart cloud service and IoT-related software and hardware solutions. It specializes in product, protocol, region, and supplier agnostics. The company was founded by Liao Han Chen, Alex Yang, Ruixin Zhou, and Xue Ji Wang on June 16, 2014 and is headquartered in Hangzhou, China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HUANG SIDNEY XUANDEDirectorJul 07 '25Proposed Sale2.4740,00098,800Jul 07 07:00 AM
ARMP - Armata Pharmaceuticals Inc - Stock Price Chart
TickerARMP [AMEX]
CompanyArmata Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap89.03MEPS (ttm)-0.54
P/E-EPS this Y-117.98%
Forward P/E-EPS next Y-
PEG-EPS past 5Y26.80%
P/S18.94EPS next 5Y-
P/B-EPS Q/Q73.94%
Dividend-Sales Q/Q-49.17%
Insider Own70.20%Inst Own2.05%
Insider Trans0.00%Inst Trans-46.04%
Short Float0.96%EarningsMay 14/a
Analyst Recom1.00Target Price9.00
Avg Volume255.33K52W Range0.90 - 3.42
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.
BILI - Bilibili Inc ADR - Stock Price Chart
TickerBILI [NASD]
CompanyBilibili Inc ADR
CountryChina
IndustryInternet Content & Information
Market Cap7.83BEPS (ttm)-0.20
P/E-EPS this Y10026.07%
Forward P/E23.96EPS next Y44.43%
PEG-EPS past 5Y1.81%
P/S2.01EPS next 5Y-
P/B5.00EPS Q/Q98.80%
Dividend-Sales Q/Q22.13%
Insider Own0.00%Inst Own21.74%
Insider Trans-Inst Trans-1.73%
Short Float4.46%EarningsMay 20/b
Analyst Recom1.52Target Price25.12
Avg Volume3.45M52W Range12.72 - 31.77
Bilibili, Inc. is a holding company, which engages in the provision of online entertainment content. The firm enables broad video-based content consumption scenarios centered around professional user generated videos supplemented with live broadcasting, occupationally generated videos, or occupationally generated videos. The company was founded by Xu Yi in June 2009 and is headquartered Shanghai, China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kami Sama LimitedAffiliateMar 26 '25Proposed Sale19.871,500,00029,805,000Mar 26 09:00 AM
Vanship LimitedAffiliateDec 03 '24Proposed Sale18.39525,5259,664,405Dec 03 08:29 AM
Saber Lily LimitedAffiliateDec 03 '24Proposed Sale18.39908,30016,703,637Dec 03 08:27 AM
MIST - Milestone Pharmaceuticals Inc - Stock Price Chart
TickerMIST [NASD]
CompanyMilestone Pharmaceuticals Inc
CountryCanada
IndustryBiotechnology
Market Cap79.13MEPS (ttm)-0.83
P/E-EPS this Y-27.99%
Forward P/E-EPS next Y-12.73%
PEG-EPS past 5Y28.21%
P/S-EPS next 5Y6.94%
P/B-EPS Q/Q-51.74%
Dividend-Sales Q/Q-
Insider Own1.06%Inst Own22.27%
Insider Trans0.00%Inst Trans-39.21%
Short Float3.72%EarningsMay 14/b
Analyst Recom2.00Target Price3.33
Avg Volume1.48M52W Range0.63 - 2.75
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.
WIMI - Wimi Hologram Cloud Inc - Stock Price Chart
TickerWIMI [NASD]
CompanyWimi Hologram Cloud Inc
CountryChina
IndustryAdvertising Agencies
Market Cap33.49MEPS (ttm)0.51
P/E6.72EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-16.35%
P/S0.44EPS next 5Y-
P/B0.49EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own31.45%Inst Own1.31%
Insider Trans0.00%Inst Trans-99.19%
Short Float9.59%Earnings-
Analyst Recom-Target Price-
Avg Volume723.55K52W Range2.24 - 29.20
WiMi Hologram Cloud, Inc. engages in the provision of holographic services and products. It offers comprehensive solutions including AR automotive HUD software, 3D holographic pulse LiDAR, head-mounted light field equipment, holographic semiconductors, cloud software, and car navigation systems. Its services and holographic AR technologies include holographic AR automotive application, 3D holographic pulse LiDAR technology, holographic vision semiconductor technology, holographic software development, holographic AR advertising technology, holographic AR entertainment technology, holographic ARSDK payment, interactive holographic communication and other holographic AR technologies. The firm operates through the following segments: AR Advertising Services, AR Entertainment, and Semiconductor Business. The AR Advertising Services segment enables the integration of real or animated 3D objects into video footage, creating seamless and interactive visual experiences. The AR Entertainment segment focuses on payment middleware software, game distribution platforms, and holographic MR software. The Semiconductor Business segment provides central processing algorithm services, computer chip products, and comprehensive solutions integrating software and hardware for enterprise customers. The company was founded by Jie Zhao in May 2015 and is headquartered in Chaoyang, China.
DMAC - DiaMedica Therapeutics Inc - Stock Price Chart
TickerDMAC [NASD, RUT]
CompanyDiaMedica Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap184.40MEPS (ttm)-0.65
P/E-EPS this Y-29.44%
Forward P/E-EPS next Y-2.58%
PEG-EPS past 5Y7.39%
P/S-EPS next 5Y-14.05%
P/B5.43EPS Q/Q-32.57%
Dividend-Sales Q/Q-
Insider Own43.69%Inst Own17.86%
Insider Trans0.00%Inst Trans11.05%
Short Float8.79%EarningsMay 13/a
Analyst Recom1.00Target Price9.67
Avg Volume179.23K52W Range3.19 - 6.82
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pilnik Richard D.DirectorApr 07 '25Option Exercise2.1124,00050,640312,995Apr 08 04:41 PM
Giuffre Randall MichaelDirectorFeb 13 '25Option Exercise2.5617,00043,570392,412Feb 18 04:25 PM
HYPD - Hyperion DeFi Inc - Stock Price Chart
TickerHYPD [NASD]
CompanyHyperion DeFi Inc
CountryUSA
IndustryBiotechnology
Market Cap37.14MEPS (ttm)-44.81
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y12.70%
P/S530.64EPS next 5Y-
P/B-EPS Q/Q91.51%
Dividend-Sales Q/Q194.81%
Insider Own21.20%Inst Own23.71%
Insider Trans0.00%Inst Trans0.62%
Short Float9.55%EarningsMay 19/a
Analyst Recom3.00Target Price2.00
Avg Volume4.63M52W Range0.85 - 124.80
Hyperion DeFi, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rowe Michael MChief Executive OfficerAug 28 '24Buy0.5227,07114,077109,998Aug 28 08:01 PM
Rowe Michael MChief Executive OfficerAug 26 '24Buy0.5750,00028,50082,927Aug 27 01:06 PM
TSAT - Telesat Corp - Stock Price Chart
TickerTSAT [NASD]
CompanyTelesat Corp
CountryCanada
IndustryCommunication Equipment
Market Cap397.68MEPS (ttm)-4.67
P/E-EPS this Y0.15%
Forward P/E-EPS next Y-64.87%
PEG-EPS past 5Y-
P/S1.03EPS next 5Y-20.03%
P/B0.79EPS Q/Q5.71%
Dividend-Sales Q/Q-27.89%
Insider Own9.10%Inst Own56.82%
Insider Trans0.00%Inst Trans0.43%
Short Float5.80%EarningsMay 06/b
Analyst Recom2.00Target Price25.59
Avg Volume103.15K52W Range7.21 - 27.45
Telesat Corp. engages in the provision of satellite communications and consulting services. It operates through Geostationary (GEO) and Low Earth Orbit (LEO) segments. It is a global satellite operator, providing mission-critical communications solutions to support the requirements of sophisticated satellite users throughout the world and consists of 14 geostationary satellites and the Canadian payload on Viasat-1. The company was founded in 1969 and is headquartered in Ottawa, Canada.
MYNZ - Mainz Biomed N.V - Stock Price Chart
TickerMYNZ [NASD]
CompanyMainz Biomed N.V
CountryGermany
IndustryDiagnostics & Research
Market Cap7.56MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-52.02%
P/S-EPS next 5Y-
P/B-EPS Q/Q-1121.45%
Dividend-Sales Q/Q-
Insider Own3.35%Inst Own6.13%
Insider Trans0.00%Inst Trans0.11%
Short Float1.72%EarningsApr 01/b
Analyst Recom1.00Target Price14.00
Avg Volume181.88K52W Range1.34 - 19.00
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
ONC - BeOne Medicines Ltd ADR - Stock Price Chart
TickerONC [NASD]
CompanyBeOne Medicines Ltd ADR
CountrySwitzerland
IndustryBiotechnology
Market Cap29.56BEPS (ttm)-3.71
P/E-EPS this Y125.13%
Forward P/E48.56EPS next Y261.76%
PEG-EPS past 5Y17.26%
P/S7.08EPS next 5Y-
P/B8.32EPS Q/Q100.47%
Dividend-Sales Q/Q48.64%
Insider Own0.89%Inst Own38.42%
Insider Trans-59.07%Inst Trans-11.90%
Short Float1.66%EarningsMay 07/b
Analyst Recom1.16Target Price335.05
Avg Volume364.22K52W Range146.21 - 287.88
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OYLER JOHNChief Executive OfficerJul 09 '25Sale253.3827,8027,044,5910Jul 11 05:14 PM
JOHN V OYLERDirectorJul 09 '25Proposed Sale244.4727,8026,796,755Jul 09 04:15 PM
PAN-OYLER FOUNDATIONDirectorJul 08 '25Proposed Sale240.991,661400,284Jul 08 04:21 PM
Wang LaiGlobal Head of R&DJun 23 '25Sale260.001,028267,2800Jun 25 05:09 PM
Wu XiaobinPresident and COOJun 23 '25Sale260.001,363354,3800Jun 25 05:08 PM
1789101112131415161718